Nuveen Asset Management, LLC Stoke Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 108,087 shares of STOK stock, worth $3.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

108,087

Previous 108,087 -0.0%

Holding current value

$3.3 Million

Previous $1.33 Million 10.24%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$12.24 - $15.92 $970,191 - $1.26 Million	-79,264 Reduced 42.31%	108,087 $1.33 Million
Q2 2024 Aug 09, 2024	BUY	$11.03 - $17.52 $744,966 - $1.18 Million	67,540 Added 56.37%	187,351 $2.53 Million
Q1 2024 May 13, 2024	BUY	$4.12 - $14.17 $232,697 - $800,321	56,480 Added 89.18%	119,811 $1.62 Million
Q4 2023 Feb 14, 2024	BUY	$3.37 - $5.4 $1,573 - $2,521	467 Added 0.74%	63,331 $333,000
Q3 2023 Nov 14, 2023	SELL	$3.78 - $11.99 $2,884 - $9,148	-763 Reduced 1.2%	62,864 $247,000
Q2 2023 Aug 14, 2023	BUY	$7.93 - $13.82 $60,014 - $104,589	7,568 Added 13.5%	63,627 $676,000
Q1 2023 May 15, 2023	SELL	$7.65 - $10.38 $49,916 - $67,729	-6,525 Reduced 10.43%	56,059 $466,000
Q4 2022 Feb 14, 2023	SELL	$7.07 - $15.69 $267,111 - $592,783	-37,781 Reduced 37.64%	62,584 $578,000
Q3 2022 Nov 14, 2022	BUY	$12.56 - $22.53 $330,692 - $593,192	26,329 Added 35.56%	100,365 $1.29 Million
Q2 2022 Aug 15, 2022	BUY	$10.36 - $23.93 $167,386 - $386,637	16,157 Added 27.92%	74,036 $978,000
Q1 2022 May 16, 2022	BUY	$17.19 - $26.1 $12,411 - $18,844	722 Added 1.26%	57,879 $1.39 Million
Q4 2021 Feb 14, 2022	SELL	$18.11 - $30.72 $84,609 - $143,523	-4,672 Reduced 7.56%	57,157 $1.02 Million
Q3 2021 Nov 12, 2021	SELL	$23.65 - $34.44 $724,186 - $1.05 Million	-30,621 Reduced 33.12%	61,829 $1.56 Million
Q2 2021 Aug 16, 2021	BUY	$30.53 - $41.09 $1.25 Million - $1.68 Million	40,860 Added 79.2%	92,450 $3.11 Million
Q1 2021 May 17, 2021	BUY	$36.08 - $69.81 $17,318 - $33,508	480 Added 0.94%	51,590 $2 Million
Q4 2020 Feb 16, 2021	BUY	$33.62 - $61.93 $38,494 - $70,909	1,145 Added 2.29%	51,110 $3.17 Million
Q3 2020 Nov 16, 2020	SELL	$22.23 - $37.48 $137,448 - $231,738	-6,183 Reduced 11.01%	49,965 $1.67 Million
Q2 2020 Aug 14, 2020	SELL	$20.26 - $29.73 $607,030 - $890,770	-29,962 Reduced 34.8%	56,148 $1.34 Million
Q1 2020 May 14, 2020	BUY	$16.8 - $34.15 $1.09 Million - $2.21 Million	64,698 Added 302.16%	86,110 $1.97 Million
Q4 2019 Feb 14, 2020	SELL	$20.01 - $30.79 $39,759 - $61,179	-1,987 Reduced 8.49%	21,412 $606,000
Q3 2019 Nov 14, 2019	BUY	$20.53 - $37.72 $480,381 - $882,610	23,399 New	23,399 $503,000

Others Institutions Holding STOK

# of Institutions

139

Shares Held

58M

Call Options Held

2.7K

Put Options Held

57.4K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $1.2B
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Stoke Therapeutics, Inc. Transaction History